Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4644914
Max Phase: Preclinical
Molecular Formula: C51H49F3N12O7
Molecular Weight: 999.02
Molecule Type: Unknown
Associated Items:
ID: ALA4644914
Max Phase: Preclinical
Molecular Formula: C51H49F3N12O7
Molecular Weight: 999.02
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(C(=O)Nc2ccc(CN3CCN(C(=O)CCCc4cn(CCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
Standard InChI: InChI=1S/C51H49F3N12O7/c1-32-10-11-34(27-33(32)13-15-38-29-56-43-8-4-18-57-66(38)43)47(69)58-36-14-12-35(40(28-36)51(52,53)54)30-62-20-22-63(23-21-62)45(68)9-2-5-37-31-64(61-60-37)24-26-73-25-19-55-41-7-3-6-39-46(41)50(72)65(49(39)71)42-16-17-44(67)59-48(42)70/h3-4,6-8,10-12,14,18,27-29,31,42,55H,2,5,9,16-17,19-26,30H2,1H3,(H,58,69)(H,59,67,70)
Standard InChI Key: VCIZNIVXZWDIOC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 999.02 | Molecular Weight (Monoisotopic): 998.3799 | AlogP: 4.50 | #Rotatable Bonds: 16 |
Polar Surface Area: 218.36 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.59 | CX Basic pKa: 5.77 | CX LogP: 4.76 | CX LogD: 4.75 |
Aromatic Rings: 6 | Heavy Atoms: 73 | QED Weighted: 0.07 | Np Likeness Score: -1.56 |
1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y.. (2020) Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects., 63 (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967] |
Source(1):